Recent research has shown that curcumin targets cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, through increased apoptosis and decreased levels of cancer stem cell markers (Nanog, Oct-3/4, HNF/FoxA2, VEGFR, ALDH1) [201]. This evidence concerns the gene NEFH and cancer.